Skip to main content
. 2023 Sep 21;14:1244361. doi: 10.3389/fendo.2023.1244361

Table 3.

Characteristics of patients based on genetic test outcomes.

Subjects with positive genetic test
(n = 5)
Subjects with negative genetic test
(n = 35)
P-value
Age at diagnosis (years) 54.2 ± 16 50.8 ± 15 0.6526
Calcium (mmol/L) 3.36 ± 0.49 2.99 ± 0.49 0.0817
PTH (pmol/L) 134.95 ± 159.25 38.18 ± 48.65 0.1582
Mean P min pre-surgery (mmol/L) 0.63 ± 0.19 0.87 ± 0.4 0.1005
Calcium creatinine clearance ratio (CCCR)* 0.0085 0.022 0.0057
More than one inclusion criteria (%) 3/5 (60 %) 10/35 (28.6 %) 0.1605

Data are expressed as mean ± standard deviation. The positive genetic test group included patients with LP or P variants, according to the ACMG criteria. The negative genetic test group included subjects with VUS variants or those without any variants found in the genes studied. *CCCR was analysed with Wilcoxon test being lower in subjects with class LP or P variants when compared to subjects with negative genetic test (P = 0.005). When analysing the differences in CCCR between patients who presented with each type of mutation (CASR, CDKN1B, or non-mutated; Kruskal-Wallis test), a statistically significant difference was observed (P = 0.02), mainly at the expense of subjects with mutated CASR, in whom the CCCR value was much lower.